Literature DB >> 9200453

TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.

J J Bright1, L D Kerr, S Sriram.   

Abstract

Signaling through IL-2R, IL-2 induces tyrosine phosphorylation and activation of Jak-1 and Jak-3 kinases and Stat 3 and Stat 5 transcription factors leading to cell cycle progression of activated T cells from G1 to S phase. TGF-beta is an immunosuppressive cytokine, which inhibits T cell proliferation at G1 to S phase transition. We examined the effect of TGF-beta on IL-2R signal transduction pathway in activated T cells. We show here that treatment of activated T cells with TGF-beta inhibited IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 but not Jak-3 and Stat 3. TGF-beta also inhibited IL-2-induced expression of alpha- and beta-chains of IL-2R and induced apoptotic cell death in T cells. These results suggest that TGF-beta-induced growth arrest and apoptosis are associated with the modulation of IL-2-induced activation of Jak-Stat pathway in T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200453

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Immunotherapy of inflammatory demyelinating diseases of the central nervous system.

Authors:  J J Bright; S Sriram
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells.

Authors:  Ivan Rajkovic; Ana Dragicevic; Sasa Vasilijic; Biljana Bozic; Tanja Dzopalic; Sergej Tomic; Ivana Majstorovic; Dragana Vucevic; Jelena Djokic; Bela Balint; Miodrag Colic
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

3.  Transforming growth factor-beta downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma.

Authors:  Cheryn Song; Sun-Young Jun; Jun-Hyuk Hong; Hanjong Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2007-02-06       Impact factor: 4.553

4.  COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis.

Authors:  Gladson Muthian; Himanshu P Raikwar; Caroline Johnson; Johnson Rajasingh; Amit Kalgutkar; Lawrence J Marnett; John J Bright
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

Review 5.  Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

Authors:  Marina Gazdic; Vladislav Volarevic; Nebojsa Arsenijevic; Miodrag Stojkovic
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

6.  CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer.

Authors:  I Hellstrom; J A Ledbetter; N Scholler; Y Yang; Z Ye; G Goodman; J Pullman; M Hayden-Ledbetter; K E Hellstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

7.  Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells.

Authors:  H K Sillett; S M Cruickshank; J Southgate; L K Trejdosiewicz
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

8.  Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.

Authors:  T J Sullivan; J J Letterio; A van Elsas; M Mamura; J van Amelsfort; S Sharpe; B Metzler; C A Chambers; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

9.  Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.

Authors:  T K Sengupta; E S Talbot; P A Scherle; L B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

10.  Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.

Authors:  Gladson Muthian; John J Bright
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.